• MS Medications

  European Medicine Backing off Lemtrada

  Posted by ed-tobias on April 13, 2019 at 2:29 pm

  

  The European Medicines Agency is recommending that Lemtrada (alembuzamab) only be used to treat people whose MS is “highly active” and who have failed two other MS medications. This is a tightening of its recommendation for this DMT while the agency conducts a safety review.

  If you’re in Europe, what do you think about this?

  https://www.ema.europa.eu/en/medicines/human/referrals/lemtrada

  ed-tobias replied 5 years, 8 months ago 1 Member · 0 Replies

  • alemtuzumab
  • EMA
  • European Medicines Agency
  • Lemtrada
• 0 Replies

Log In to Reply